Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Bateman

Showing results (31-40 of 161) with videos related to

Pageof 17
Sort By:
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|June 7, 2007
Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate aloneAshley A Woodcock, Alfredas Bagdonas, Watchara Boonsawat, et al.
The European Respiratory Journal|June 1, 2013
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEric D Bateman, Gary T Ferguson, Neil Barnes, et al.
The Journal of Allergy and Clinical Immunology|October 16, 2007
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL studySøren E Pedersen, Eric D Bateman, Jean Bousquet, et al.
BMC Pulmonary Medicine|July 11, 2014
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised studyAshley Woodcock, Jan Lötvall, William W Busse, et al.
Expert Review of Respiratory Medicine|May 8, 2014
Recent advances in COPD disease management with fixed-dose long-acting combination therapiesEric D Bateman, Donald A Mahler, Claus F Vogelmeier, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2015
Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysisEric D Bateman, Dirk Esser, Costel Chirila, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2018
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic AsthmaEric D Bateman, Ratko Djukanović, Mario Castro, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 19, 2007
Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the goal studyEric D Bateman, Tim J H Clark, Lucy Frith, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 12, 2003
The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing countryHeather J. Zar, Patti Apolles, Andrew Argent, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyClaus F Vogelmeier, Eric D Bateman, John Pallante, et al.
Pageof 17

Showing results (31-40 of 161) with videos related to

Sort By:
Pageof 17
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|June 7, 2007
Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate aloneAshley A Woodcock, Alfredas Bagdonas, Watchara Boonsawat, et al.
The European Respiratory Journal|June 1, 2013
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE studyEric D Bateman, Gary T Ferguson, Neil Barnes, et al.
The Journal of Allergy and Clinical Immunology|October 16, 2007
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL studySøren E Pedersen, Eric D Bateman, Jean Bousquet, et al.
BMC Pulmonary Medicine|July 11, 2014
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised studyAshley Woodcock, Jan Lötvall, William W Busse, et al.
Expert Review of Respiratory Medicine|May 8, 2014
Recent advances in COPD disease management with fixed-dose long-acting combination therapiesEric D Bateman, Donald A Mahler, Claus F Vogelmeier, et al.
The Journal of Allergy and Clinical Immunology|May 5, 2015
Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysisEric D Bateman, Dirk Esser, Costel Chirila, et al.
American Journal of Respiratory and Critical Care Medicine|October 23, 2018
Predicting Responders to Reslizumab after 16 Weeks of Treatment Using an Algorithm Derived from Clinical Studies of Patients with Severe Eosinophilic AsthmaEric D Bateman, Ratko Djukanović, Mario Castro, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 19, 2007
Rate of response of individual asthma control measures varies and may overestimate asthma control: an analysis of the goal studyEric D Bateman, Tim J H Clark, Lucy Frith, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 12, 2003
The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing countryHeather J. Zar, Patti Apolles, Andrew Argent, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group studyClaus F Vogelmeier, Eric D Bateman, John Pallante, et al.
Pageof 17